Georgejason/iStock Editorial via Getty Images Illumina ( NASDAQ: ILMN ) has been cut to underweight from equal weight by Barclays over concerns the company may be facing sanctions in China and risks to its 2025 and long-range guidance. "Given our ratings are relative to our universe, we struggle to